MediPharm Labs Corp logo

MediPharm Labs Corp

STU:MLZ (Canada)  
€ 0.04 (-0.45%) May 6
At Loss
P/B:
0.64
Market Cap:
€ 23.42M ($ 25.22M)
Enterprise V:
€ 12.72M ($ 13.70M)
Volume:
-
Avg Vol (2M):
19.52K
Also Trade In:

Business Description

Description
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 7.84
Equity-to-Asset 0.83
Debt-to-Equity 0.04
Debt-to-EBITDA -0.22
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.65
Distress
Grey
Safe
Beneish M-Score 17.42
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 49.6
9-Day RSI 50.69
14-Day RSI 51.63
6-1 Month Momentum % 9.05
12-1 Month Momentum % 3.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.37
Quick Ratio 2.46
Cash Ratio 1.66
Days Inventory 127.51
Days Sales Outstanding 115.98
Days Payable 38.11

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -37.2
Shareholder Yield % -3.45

Financials

STU:MLZ's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

MediPharm Labs Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 22.776
EPS (TTM) (€) -0.028
Beta 2.21
Volatility % 78.24
14-Day RSI 51.63
14-Day ATR (€) 0.006404
20-Day SMA (€) 0.04388
12-1 Month Momentum % 3.48
52-Week Range (€) 0.0269 - 0.0716
Shares Outstanding (Mil) 404.05

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MediPharm Labs Corp Filings

Filing Date Document Date Form
No Filing Data

MediPharm Labs Corp Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

MediPharm Labs Corp Frequently Asked Questions

What is MediPharm Labs Corp(STU:MLZ)'s stock price today?
The current price of STU:MLZ is €0.04. The 52 week high of STU:MLZ is €0.07 and 52 week low is €0.03.
When is next earnings date of MediPharm Labs Corp(STU:MLZ)?
The next earnings date of MediPharm Labs Corp(STU:MLZ) is .
Does MediPharm Labs Corp(STU:MLZ) pay dividends? If so, how much?
MediPharm Labs Corp(STU:MLZ) does not pay dividend.

Press Release

Subject Date
No Press Release